Cancer Immunotherapy Using Chimeric Antigen Receptor Expressing T-Cells: Present and Future Needs of Clinical Cancer Centers

by Gotti, Manuel, Defrancesco, Irene, D’Angelo, Mario, Basso, Sabrina, Crotto, Luca, Marinelli, Alfredo, Maccalli, Cristina, Iaconianni, Vincenzo
Published in Front Immunol (2020)

High-dose fotemustine in temozolomide-pretreated glioblastoma multiforme patients: A phase I/II trial

by Marinelli, Alfredo, Lamberti, Giuseppe, Cerbone, Luigi, Cordua, Nadia, Buonerba, Carlo, Peluso, Gianfranco, Di Lorenzo, Giuseppe, De Placido, Sabino
Published in Medicine (Baltimore) (2018)

Biweekly fotemustine schedule for recurrent glioblastoma in the elderly: activity and toxicity assessment of a multicenter study

by Addeo, Raffaele, Lamberti, Giuseppe, Simonetti, Giorgia, Iodice, Patrizia, Marinelli, Alfredo, Montella, Liliana, Cappabianca, Salvatore, Gaviani, Paola, Caraglia, Michele, Prete, Salvatore Del, Silvani, Antonio
Published in CNS Oncol (2019)

High grade glioblastoma is associated with aberrant expression of ZFP57, a protein involved in gene imprinting, and of CPT1A and CPT1C that regulate fatty acid metabolism

by Cirillo, Alessandra, Di Salle, Anna, Petillo, Orsolina, Melone, Mariarosa AB, Grimaldi, Giovanna, Bellotti, Alfredo, Torelli, Giovanni, de’ Santi, Maria Serena, Cantatore, Giovanna, Marinelli, Alfredo, Galderisi, Umberto, Peluso, Gianfranco
Published 2014

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial

by Buonerba, Carlo, De Placido, Pietro, Bruzzese, Dario, Pagliuca, Martina, Ungaro, Paola, Bosso, Davide, Ribera, Dario, Iaccarino, Simona, Scafuri, Luca, Liotti, Antonietta, Romeo, Valeria, Izzo, Michela, Perri, Francesco, Casale, Beniamino, Grimaldi, Giuseppe, Vitrone, Francesca, Brunetti, Arturo, Terracciano, Daniela, Marinelli, Alfredo, De Placido, Sabino, Di Lorenzo, Giuseppe
Published in Front Pharmacol (2018)